The development of NASH is often associate with small intestinal bacterial overgrowth, a condition characterized by increased expression of TLR4 on CD14 positive monocytes and higher plasma IL-8 levels [498]. Here, CD14 is linked to metabolic dysfunction-associated steatohepatitis.